Neema Mafi is an Infectious Disease physician. OpenAlex indexes 8 publications with 532 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
19841 N 27th Ave Ste 403
Phoenix, AZ 850274007
Telephone
602-439-0274Provider last certified this registry record 2 May 2025.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year20251 payment
- Astellas Pharma US IncProgram year20251 payment
- Paratek Pharmaceuticals, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
95.6%Cephalosporin Antibacterial35.5%Ceftriaxone33%Cefepime Hcl27%Cefazolin Sodium20%Cefuroxime20%Part D<11 patientsLipopeptide Antibacterial15%Daptomycin100%Part D≥15 patients+ 8 more classes in this area
Sensory organs
4.4%Fluoroquinolone Antibacterial4.4%Ciprofloxacin Hcl100%Part D≥17 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Human Dectin-1 deficiency impairs macrophage-mediated defense against phaeohyphomycosis
Journal of Clinical Investigation
2022 - 286. Prevalence and Clinical Outcomes of COVID-Associated Pulmonary Fibrosis
Open Forum Infectious Diseases
2022 - Tick-Borne Relapsing Fever in the White Mountains, Arizona, USA, 2013–2018
Emerging infectious diseases
2019 - 261. A Retrospective Evaluation of Coccidioidomycosis Skin Testing in Patients with Pulmonary Coccidioidomycosis in an Endemic Region
Open Forum Infectious Diseases
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Yousef Khader
Jordan University of Science and Technology
Andrew Rambaut
University of Edinburgh
Olayinka Stephen Ilesanmi
University College Hospital
Maysaa El Sayed Zaki
Mansoura University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”